Eric Collisson, MD | American Lung Association

Eric Collisson, MD

Research Awards Nationwide Recipient (2015-2016)

University of California, San Francisco
Funding in Partnership with the American Lung Association of the Upper Midwest
Using Genomics to Attack Lung Cancer

While we are gaining insight into the workings of the lung cancer cell by the use of genome sequencing, our efforts at personalizing treatments currently only help about one in five patients. We will use new therapies being developed to attack lung cancer, using mutant cancer genes against the tumor's own growth. We will examine how a gene complex responsible for managing the way other genes are packaged affects the transformation of normal lung cells to cancer cells. We will also look at how mutations in a specific gene affect the formation and the progression of lung cancer.

Update: We have been studying a class of genes called the SWI/SNF genes in lung cancer. Our experiments have shown that mutations in these genes are likely early events in the establishment and evolution of cancer. We now think the genes may be involved in both early initiation of the cancer and its later growth and are trying to learn more about the liabilities cancer cells harboring these mutations have, and how we might capitalize on them.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.